ESMO 2017: Press Releases

Press Releases from the ESMO 2017 Congress

Filter

Date Title Topic
12 Sep 2017 ESMO 2017 Press Release: Best Poster at ESMO 2017 Shows Positive Trials Twice as Likely to be Reported in Lay Press
12 Sep 2017 ESMO 2017 Press Release: Best of ESMO 2017 Congress
11 Sep 2017 ESMO 2017 Press Release: Debate on Duration of Colon Cancer Adjuvant Chemotherapy Takes Centre Stage at ESMO 2017 Gastrointestinal cancers
11 Sep 2017 ESMO 2017 Press Release: Combination Targeted Adjuvant Therapy Doubles Relapse-free Survival in Stage III Melanoma Melanoma and other skin tumours
11 Sep 2017 ESMO 2017 Press Release: Adjuvant Nivolumab Superior to Ipilimumab in Surgically Resected Stage III/IV Melanoma Melanoma and other skin tumours
11 Sep 2017 ESMO 2017 Press Release: KEYNOTE-040 Evaluates Pembrolizumab in Head and Neck Cancer Head and neck cancers
10 Sep 2017 ESMO 2017 Media Alert: ESMO 2017 Shows Support for World Cancer Research Day
10 Sep 2017 ESMO 2017 Press Release: Mature Results Favour Pembrolizumab As Second-line Treatment For Bladder Cancer Genitourinary cancers
10 Sep 2017 ESMO 2017 Press Release: Licensing and Reimbursement Discrepancies Impact Patient Access to Cancer Treatment
10 Sep 2017 ESMO 2017 Press Release: Abemaciclib Initial Therapy Improves Outcome in Endocrine-sensitive Advanced Breast Cancer Breast cancer
10 Sep 2017 ESMO 2017 Press Release: Abdominal Fat a Key Cancer Driver for Postmenopausal Women
10 Sep 2017 ESMO 2017 Press Release: Ramucirumab plus Docetaxel Improves Progression-free survival in Urothelial Cancer Genitourinary cancers
10 Sep 2017 ESMO 2017 Press Release: Combination Immunotherapy in Second/third Line Extends Mesothelioma Survival to 15 Months Lung and other thoracic tumours
10 Sep 2017 ESMO 2017 Press Release: Study Shows ESMO Magnitude of Benefit Scale Can Be Used to Grade Orphan Drugs
10 Sep 2017 ESMO 2017 Press Release: Cancer Patients Struggle with Key Aspects of Clinical Trial Methodology